
Sign up to save your podcasts
Or


Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
By The Lancet Group5
66 ratings
Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

43,657 Listeners

7,709 Listeners

317 Listeners

498 Listeners

299 Listeners

50 Listeners

126 Listeners

8,554 Listeners

23 Listeners

188 Listeners

239 Listeners

15,634 Listeners

38 Listeners

81 Listeners